Salidroside protects against T1DM-induced kidney injury and renal fibrosis by ameliorating TGF-β1 and the Wnt1/3a/β-catenin signaling pathway (Shati and Alfaifi, 2020). The gene discussed is TGFB1; the disease is renal fibrosis.